{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T18:26:16Z","timestamp":1771611976407,"version":"3.50.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1097\/inf.0000000000000677","type":"journal-article","created":{"date-parts":[[2015,3,20]],"date-time":"2015-03-20T15:31:16Z","timestamp":1426865476000},"page":"557-561","source":"Crossref","is-referenced-by-count":24,"title":["Comparative Epidemiology of Streptococcus pyogenes emm-Types Causing Invasive and Noninvasive Infections in French Children by Use of High-Resolution Melting-Polymerase Chain Reaction"],"prefix":"10.1097","volume":"34","author":[{"given":"Camille","family":"d\u2019Humi\u00e8res","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Bidet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"B\u00e9chet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Bonacorsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edouard","family":"Bingen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-1-20210202","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/jac\/dkl101","article-title":"Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA.","volume":"57","author":"Green","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"R2-1-20210202","doi-asserted-by":"crossref","first-page":"E222","DOI":"10.1111\/1469-0691.12134","article-title":"Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study.","volume":"19","author":"McMillan","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"R4-1-20210202","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1007\/s10096-012-1635-5","article-title":"Identification of group A streptococcal emm types commonly associated with invasive infections and antimicrobial resistance by the use of multiplex PCR and high-resolution melting analysis.","volume":"31","author":"Bidet","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R5-1-20210202","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1473-3099(09)70178-1","article-title":"Global emm type distribution of group A streptococci: systematic review and implications for vaccine development.","volume":"9","author":"Steer","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"R6-1-20210202","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1086\/379230","article-title":"Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates.","volume":"188","author":"Schmitz","year":"2003","journal-title":"J Infect Dis"},{"key":"R7-1-20210202","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1086\/444458","article-title":"Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers.","volume":"41","author":"McNeil","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R8-1-20210202","doi-asserted-by":"crossref","first-page":"8175","DOI":"10.1016\/j.vaccine.2011.09.005","article-title":"New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci.","volume":"29","author":"Dale","year":"2011","journal-title":"Vaccine"},{"key":"R10-1-20210202","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10096-012-1809-1","article-title":"Effect of clinical spectrum, inoculum size and physician characteristics on sensitivity of a rapid antigen detection test for group A streptococcal pharyngitis.","volume":"32","author":"Cohen","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R12-1-20210202","first-page":"811","article-title":"The validity of a sore throat score in family practice.","volume":"163","author":"McIsaac","year":"2000","journal-title":"CMAJ"},{"key":"R13-1-20210202","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1001\/jama.291.13.1587","article-title":"Empirical validation of guidelines for the management of pharyngitis in children and adults.","volume":"291","author":"McIsaac","year":"2004","journal-title":"JAMA"},{"key":"R14-1-20210202","first-page":"75","article-title":"A clinical score to reduce unnecessary antibiotic use in patients with sore throat.","volume":"158","author":"McIsaac","year":"1998","journal-title":"CMAJ"},{"key":"R15-1-20210202","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.arcped.2009.10.005","article-title":"Streptococcus pyogenes or group A streptococcal infections in child: French national reference center data.","volume":"17","author":"Bidet","year":"2010","journal-title":"Arch Pediatr"},{"key":"R17-1-20210202","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1574-695X.2010.00652.x","article-title":"Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003-2007.","volume":"58","author":"Imohl","year":"2010","journal-title":"FEMS Immunol Med Microbiol"},{"key":"R19-1-20210202","first-page":"21","article-title":"Clinical and microbiological characteristics of severe streptococcus pyogenes disease in Europe.","volume":"21","author":"Luca-Harari","year":"2009","journal-title":"J Clin Microbiol"},{"key":"R20-1-20210202","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1128\/IAI.63.3.994-1003.1995","article-title":"Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease.","volume":"63","author":"Musser","year":"1995","journal-title":"Infect Immun"},{"key":"R21-1-20210202","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1086\/521264","article-title":"Active Bacterial Core Surveillance Team. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004.","volume":"45","author":"OLoughlin","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R22-1-20210202","doi-asserted-by":"crossref","first-page":"E1768","DOI":"10.1073\/pnas.1403138111","article-title":"Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences.","volume":"111","author":"Nasser","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R24-1-20210202","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.3201\/eid1711.110159","article-title":"Group A Streptococcus emm gene types in pharyngeal isolates, Ontario, Canada, 2002-2010.","volume":"17","author":"Shea","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"R25-1-20210202","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.diagmicrobio.2010.09.011","article-title":"Molecular analysis of Streptococcus pyogenes strains isolated from Chinese children with pharyngitis.","volume":"69","author":"Chang","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R27-1-20210202","first-page":"55","article-title":"Molecular epidemiology of group A streptococcus from pharyngeal isolates in Auckland, New Zealand, 2013.","volume":"127","author":"Williamson","year":"2014","journal-title":"N Z Med J"},{"key":"R28-1-20210202","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1016\/S0399-077X(08)73198-6","article-title":"Epidemie de scarlatine et dangine streptococcique, Hautes-Alpes et Bouches-du-Rhone, 2007.","volume":"38","author":"Franke","year":"2008","journal-title":"Med mal inf"},{"key":"R29-1-20210202","first-page":"386","article-title":"Epidemiological features and control of an outbreak of scarlet fever in a Perth primary school.","volume":"29","author":"Feeney","year":"2005","journal-title":"Commun Dis Intell Q Rep"},{"key":"R30-1-20210202","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1099\/00222615-39-3-165","article-title":"The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease.","volume":"39","author":"Colman","year":"1993","journal-title":"J Med Microbiol"},{"key":"R31-1-20210202","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1097\/INF.0b013e31825874f3","article-title":"Outbreak of scarlet fever associated with emm12 type group A Streptococcus in 2011 in Shanghai, China.","volume":"31","author":"Chen","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R33-1-20210202","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/01.inf.0000190023.89759.96","article-title":"Age influences the emm type distribution of pediatric group A streptococcal pharyngeal isolates.","volume":"24","author":"Jaggi","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R34-1-20210202","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00431-008-0819-6","article-title":"Age-associated differences in prevalence of group A streptococcal type-specific M antibodies in children.","volume":"168","author":"Jaggi","year":"2009","journal-title":"Eur J Pediatr"},{"issue":"Suppl 2","key":"R36-1-20210202","doi-asserted-by":"crossref","first-page":"B216","DOI":"10.1016\/j.vaccine.2012.09.045","article-title":"Group A streptococcal vaccines: paving a path for accelerated development.","volume":"31","author":"Dale","year":"2013","journal-title":"Vaccine"},{"key":"R37-1-20210202","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/infdis\/jir149","article-title":"Defense from the Group A Streptococcus by active and passive vaccination with the streptococcal hemoprotein receptor.","volume":"203","author":"Huang","year":"2011","journal-title":"J Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000000677","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:06:43Z","timestamp":1620954403000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201506000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000000677","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}